Ziyuglycoside II Inhibits the Growth of Human Breast Carcinoma MDA-MB-435 Cells via Cell Cycle Arrest and Induction of Apoptosis through the Mitochondria Dependent Pathway

Ziyuglycoside II is one of the major active compounds of Sanguisorba officinalis L., which has a wide range of clinical applications including hemostasis, antibiosis, anti-inflammation and anti-oxidation. This study investigated the effect of ziyuglycoside II on the growth of human breast carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xue, Wang, Ke, Zhang, Kai, Huang, Biao, Zhang, Jue, Zhang, Yi, Zhu, Lan, Zhou, Bin, Zhou, Fanfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794768/
https://www.ncbi.nlm.nih.gov/pubmed/24005866
http://dx.doi.org/10.3390/ijms140918041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794768/
https://www.ncbi.nlm.nih.gov/pubmed/24005866
http://dx.doi.org/10.3390/ijms140918041

Ejemplares similares